Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|1|77-85

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.1, 2014-01, pp. : 77-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2973-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1645-1653

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)

By  

Oncology, Vol. 89, Iss. 2, 2015-03 ,pp. : 70-78

Karger

Access to resources Recommend Favorite

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

By Gelibter Alain J.   Gamucci Teresa   Pollera Camillo F.   Di Costanzo Francesco   Nuzzo Carmen   Gabriele Angela   Signorelli Carlo   Gasperoni Silvia   Ferraresi Virginia   Giannarelli Diana   Cognetti Francesco   Zeuli Massimo  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2117-2123

Informa Healthcare

Access to resources Recommend Favorite

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2684-2693

John Wiley & Sons Inc

Access to resources Recommend Favorite